NCT03753412 Recovery From ICUAW Following Severe Respiratory and Cardiac Failure
| NCT ID | NCT03753412 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Barts & The London NHS Trust |
| Condition | Intensive Care Unit Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2019-04-09 |
| Primary Completion | 2026-09-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2019-04-09 with a primary completion date of 2026-09-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.
Eligibility Criteria
Inclusion Criteria: * Above the age of 18 * Adults with severe cardio-respiratory failure requiring ECMO. * Adults who have had personal and professional consultees agree to enrol them in the trial. Exclusion criteria: * Previous Stroke * Neuromuscular disease * Malignancy * Underlying neuromuscular disease * paediatrics
Contact & Investigator
Mark Griffiths, PhD FRCP
PRINCIPAL INVESTIGATOR
Substantive Employee and primary supervisor to PhD student
Frequently Asked Questions
Who can join the NCT03753412 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Intensive Care Unit Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03753412 currently recruiting?
Yes, NCT03753412 is actively recruiting participants. Contact the research team at Mark.griffiths@bartshealth.nhs.uk for enrollment information.
Where is the NCT03753412 trial being conducted?
This trial is being conducted at London, United Kingdom.
Who is sponsoring the NCT03753412 clinical trial?
NCT03753412 is sponsored by Barts & The London NHS Trust. The principal investigator is Mark Griffiths, PhD FRCP at Substantive Employee and primary supervisor to PhD student. The trial plans to enroll 100 participants.